)
Tango Therapeutics (TNGX) investor relations material
Tango Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Voting matters and shareholder proposals
Election of three Class II directors: Malte Peters, M.D., Kanishka Pothula, and Mace Rothenberg, M.D., with board recommendation to vote for all nominees.
Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Advisory vote to approve compensation of named executive officers, with board recommendation to vote for.
Board may consider other business that arises at the meeting or any adjournment.
Board of directors and corporate governance
Board recommends all director nominees for election to Class II positions.
Executive compensation and say-on-pay
Advisory vote on executive compensation for named executive officers is included as a proposal.
- Shareholders to vote on directors, auditor, and executive pay amid strong clinical and financial progress.TNGX
Proxy filing17 Apr 2026 - Advancing PRMT5 inhibitors for MTAP-deleted cancers with pivotal trials and strong leadership.TNGX
44th Annual J.P. Morgan Healthcare Conference13 Apr 2026 - Promising PRMT5 inhibitor data and strategic collaborations aim to reshape cancer treatment.TNGX
Leerink Global Healthcare Conference 202613 Mar 2026 - Vopimetostat delivers best-in-class efficacy and safety, driving pivotal trials and pipeline growth.TNGX
Corporate presentation11 Mar 2026 - Vopimetostat trials progress, cash runway extends to 2028, and leadership transitions completed.TNGX
Q4 20255 Mar 2026 - Pivotal trials and combination studies for vopimetostat show strong promise in cancer therapy.TNGX
TD Cowen 46th Annual Health Care Conference4 Mar 2026 - Pivotal and combination trial data for vopimetostat, plus pipeline updates, are expected this year.TNGX
Guggenheim Securities Emerging Outlook: Biotech Summit 202612 Feb 2026 - Simultaneous dose expansion of two PRMT5 inhibitors sets up major clinical readouts this year.TNGX
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026 - Second-generation PRMT5 inhibitors advance in competitive trials, with strong funding and pipeline.TNGX
2024 Wells Fargo Healthcare Conference22 Jan 2026
Next Tango Therapeutics earnings date
Next Tango Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage